Dublin, Ireland, 30 June 2022 – Orphan Drug Consulting announces the appointment of Martina White and Nicola Martone as Quality Consultants to the Orphan Drug Consulting team. 

Orphan Drug Consulting is delighted to welcome Martina White and Nicola Martone to its growing international consulting team as Quality Consultants. Martina and Nicola will join Sharon Cullen’s team of quality experts.

Martina is a Quality Consultant with over 13 years of experience in the pharmaceutical industry working across multiple areas of quality assurance. Martina has expertise in Quality, Qualification, and Validation and is an experienced Qualified Person. Martina has also held roles in manufacturing development where she led technology transfer projects and coordinated the supply of investigational medicinal products. Martina has experience with commercial product launches from a quality and validation perspective and has supported regulatory inspections across all her previous roles.

Prior to joining Orphan Drug Consulting, Martina held various roles across LEO Pharma. Most recently she led a team responsible for the QA oversight of all validation, qualification activities, and GMP projects across multiple manufacturing sites.

Martina is a registered pharmacist and has a Ph.D. from the School of Pharmacy at Trinity College Dublin.

Nicola is a Senior Quality Consultant based in The Netherlands with over 30 years of extensive experience in the pharmaceutical industry dealing with the manufacturing of APIs and finished dosage forms, including sterile and biological products. He is an EU Qualified Person since 2004.

Nicola brings applicable experience across quality management, he has expertise in Quality Systems Management, including but not limited to Inspection Readiness (FDA, EMA, Local Health Authorities, Customers), Sterility Manufacturing, and GMP Compliance Assessment, and has a solid background in Analytical Chemistry.

Prior to joining Orphan Drug Consulting, Nicola has held key quality management and/or QP roles in several companies across Europe such as Pfizer, Sandoz (Novartis Company), Centrient (formerly DSM Sinochem Pharmaceuticals), and most recently he held the position of QA project lead in Johnson & Johnson. He has contributed to the design, implementation, and maintenance of effective pharmaceutical quality systems and executed multiple internal and supplier audits focused on GMP, GDP, and regulatory compliance.

Nicola holds a Master’s Degree in Chemistry from “Federico II” University in Naples, Italy.

Coupling Martina’s and Nicola’s extensive experience in the industry helps our existing services grow and adds to the overall value proposition within Orphan Drug Consulting. 

Jason Cameron, Chief Operating Officer of Orphan Drug Consulting commented: “I am thrilled to welcome Martina and Nicola to the ever-growing team of consultants at Orphan Drug Consulting. Both Martina’s and Nicola’s experience speaks volumes making them great additions to Sharon’s expert quality team. I am confident they will be great assets to both our existing and new clients. I look forward to working closely with Martina and Nicola.

Martina adds: “I am delighted to be one of the growing number of consultants joining the Orphan Drug Consulting team. I look forward to supporting the expert team and working alongside new and existing clients.”

Nicola adds: “I am excited to join Orphan Drug Consulting as it continues to grow globally and continues to expand its services to best match the needs of its clients. I am looking forward to working closely with the Orphan Drug Consulting team at such an exciting time in their expansion.”

About Orphan Drug Consulting Ltd

Orphan Drug Consulting coordinates product launches into the US, EU, and other international markets providing strategic support in the areas of supply chain, quality assurance, vendor management, and entity management with its team of experienced industry professionals. From full-service solutions to solving specific immediate requirements, Orphan Drug Consulting is your partner of choice to manage market complexities ensuring your successful product launch to meet your patients’ needs.

For more information contact Info@orphandrugconsulting.com

Leave a reply